Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Miami, FL
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Pinellas Park, FL
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
North Chicago, IL
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
North Chicago, IL
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Hutchinson, KA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Hutchinson, KA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
New Orleans, LA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Mineola, NY
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Mineola, NY
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Duncansville, PA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
York, PA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
York, PA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
El Paso, TX
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Ft. Worth, TX
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Ft. Worth, TX
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Lewisville, TX
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Lewisville, TX
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
St. George, UT
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
St. George, UT
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Roanoke, VA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Richland, WA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Richland, WA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Tucson, AZ
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Santa Rosa, CA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Hialeah, FL
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Jacksonville, FL
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Evans, GA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Evans, GA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Charlotte, NC
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Wilmington, NC
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Columbia, SC
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Genetics of Latent Autoimmune Diabetes in Adults
A Study of the Genetic Causes of Latent Autoimmune Diabetes in Adults
Status: Enrolling
Updated:  4/12/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Genetics of Latent Autoimmune Diabetes in Adults
A Study of the Genetic Causes of Latent Autoimmune Diabetes in Adults
Status: Enrolling
Updated: 4/12/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Genetics of Latent Autoimmune Diabetes in Adults
A Study of the Genetic Causes of Latent Autoimmune Diabetes in Adults
Status: Enrolling
Updated:  4/12/2017
The University of Leicester
mi
from
Leicester,
Genetics of Latent Autoimmune Diabetes in Adults
A Study of the Genetic Causes of Latent Autoimmune Diabetes in Adults
Status: Enrolling
Updated: 4/12/2017
The University of Leicester
mi
from
Leicester,
Click here to add this to my saved trials
BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study
BD FlowSmart™ User Claims Study
Status: Enrolling
Updated:  4/12/2017
AMCR Institute, Inc
mi
from
Escondido, CA
BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study
BD FlowSmart™ User Claims Study
Status: Enrolling
Updated: 4/12/2017
AMCR Institute, Inc
mi
from
Escondido, CA
Click here to add this to my saved trials
BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study
BD FlowSmart™ User Claims Study
Status: Enrolling
Updated:  4/12/2017
Atlanta Diabetes Associates
mi
from
Atlanta, GA
BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study
BD FlowSmart™ User Claims Study
Status: Enrolling
Updated: 4/12/2017
Atlanta Diabetes Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study
BD FlowSmart™ User Claims Study
Status: Enrolling
Updated:  4/12/2017
Rocky Mountain Diabetes and Osteoporosis Center
mi
from
Idaho Falls, ID
BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study
BD FlowSmart™ User Claims Study
Status: Enrolling
Updated: 4/12/2017
Rocky Mountain Diabetes and Osteoporosis Center
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study
BD FlowSmart™ User Claims Study
Status: Enrolling
Updated:  4/12/2017
TKL research
mi
from
Fair Lawn, NJ
BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study
BD FlowSmart™ User Claims Study
Status: Enrolling
Updated: 4/12/2017
TKL research
mi
from
Fair Lawn, NJ
Click here to add this to my saved trials
Feasibility Study of Digital Photography and Group Discussion for People With Diabetes
Digital Photography and Group Discussion as a Means of Affecting Dietary Change Among People With Type 2 Diabetes: Feasibility Project
Status: Enrolling
Updated:  4/12/2017
Joslin Diabetes Center
mi
from
Boston, MA
Feasibility Study of Digital Photography and Group Discussion for People With Diabetes
Digital Photography and Group Discussion as a Means of Affecting Dietary Change Among People With Type 2 Diabetes: Feasibility Project
Status: Enrolling
Updated: 4/12/2017
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk Factors
Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk
Status: Enrolling
Updated:  4/13/2017
University of North Carolina Family Medicine Center
mi
from
Chapel Hill, NC
Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk Factors
Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk
Status: Enrolling
Updated: 4/13/2017
University of North Carolina Family Medicine Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Primary Intervention With Mucosal Insulin
Primary Intervention With Mucosal Insulin for Prevention of Type 1 Diabetes in Infants at High Genetic Risk to Develop Diabetes POINT (Primary Oral Insulin Trial) A Dose Finding and Safety Study ( Pre-POINT )
Status: Enrolling
Updated:  4/19/2017
Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Primary Intervention With Mucosal Insulin
Primary Intervention With Mucosal Insulin for Prevention of Type 1 Diabetes in Infants at High Genetic Risk to Develop Diabetes POINT (Primary Oral Insulin Trial) A Dose Finding and Safety Study ( Pre-POINT )
Status: Enrolling
Updated: 4/19/2017
Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Birmingham, AL
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Decatur, GA
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Jackson, MS
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Cleveland, OH
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Portland, OR
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Charleston, SC
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Dallas, TX
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Montgomery, AL
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Montgomery, AL
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Green Valley, AZ
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Green Valley, AZ
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Mesa, AZ
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Tempe, AZ
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Searcy, AR
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Searcy, AR
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Buena Park, CA
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Buena Park, CA
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Burbank, CA
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Burbank, CA
Click here to add this to my saved trials